Cargando…
Dopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control study
BACKGROUND: Psychosis is rare in untreated patients with Parkinson's disease (PD) but the prevalence rises to 40% during dopaminergic treatment. So far, no systematic comparison of the psychogenic potential of different dopaminergic drugs had been performed. METHODS: Eighty PD patients with psy...
Autores principales: | Ecker, Daniel, Unrath, Alexander, Kassubek, Jan, Sabolek, Michael |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704166/ https://www.ncbi.nlm.nih.gov/pubmed/19515253 http://dx.doi.org/10.1186/1471-2377-9-23 |
Ejemplares similares
-
Signal alterations of the basal ganglia in the differential diagnosis of Parkinson’s disease: a retrospective case-controlled MRI data bank analysis
por: Jesse, Sarah, et al.
Publicado: (2012) -
The treatment of Parkinson's disease with dopamine agonists
por: Konta, Brigitte, et al.
Publicado: (2008) -
S150. DOPAMINE SYNTHESIS CAPACITY IN ANTIPSYCHOTIC NAïVE FIRST EPISODE PSYCHOTIC PATIENTS
por: Sigvard, Anne, et al.
Publicado: (2018) -
Dopamine Agonist Therapy in Advanced Parkinson’s Disease
por: Reichmann, Heinz
Publicado: (2009) -
Acute Psychotic Episode Induced by Antimicrobial Treatment
por: Arain, Savera I., et al.
Publicado: (2023)